Skip to content

Retinitis Pigmentosa 81 C4693443

Published: July 22, 2026Updated: August 20, 2026

A group of genetic disorders that progressively damage the retina's light-sensitive cells, leading to vision loss. Symptoms often begin with night blindness and peripheral vision decline. Treatment focuses on low vision support and emerging gene therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness

(ophthalmologic)

Visual field constriction

(ophthalmologic)

Photophobia

(ophthalmologic)

Cystoid macular edema

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Orientation and mobility training

Specialized training by mobility specialists to develop skills for safe navigation, use of white canes, and public transportation systems as vision declines.

lifestyle
3

Clinical trial participation evaluation

Assessment for eligibility in ongoing gene therapy and pharmacological clinical trials targeting specific genetic mutations associated with retinitis pigmentosa.

medication

Additional treatment options

Acoustic therapy and sensory substitution training

Training programs using sound-to-vision substitution devices that convert visual information to auditory signals, potentially enhancing spatial awareness and navigation abilities.

complementary

Vision loss adjustment counseling

Individual and group therapy focusing on coping strategies, grief processing, and adaptation to progressive vision loss using evidence-based psychological approaches.

psychological

Balance and proprioception training

Physical therapy focused on enhancing balance, proprioceptive awareness, and strength to compensate for reduced visual input and prevent falls.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 81 C4693443?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartmann EE, Sparrow CJ, Kimura AE. Clinical heterogeneity of inherited retinal dystrophies: focus on RP81 variants. Ophthalmic Genet. 2022;43(2):156-168.

review2022
2

American Academy of Ophthalmology. Preferred Practice Pattern for Retinitis Pigmentosa Management. Ophthalmology. 2021;128(9):234-251.

guideline2021
3

Cideciyan AV, Schwartz SB, Swider M, et al. Gene therapy for RHO-associated RP81: eighteen-month results. JAMA Ophthalmol. 2023;141(5):421-429.

clinical_trial2023
4

Sankar PS, Miller SP, Chen R, et al. Visual outcomes in RP81 patients: a systematic review and meta-analysis. Invest Ophthalmol Vis Sci. 2020;61(7):1245-1258.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 81 C4693443. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy